Sumitani M - Search Results

1

A decision tree prediction model for a short-term outcome of delirium in patients with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R).

Kurisu K, Inada S, Maeda I, Ogawa A, Iwase S, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Nakahara R, Kaneishi K, Nakajima N, Sumitani M, Yoshiuchi K; Phase-R Delirium Study Group. Kurisu K, et al. Among authors: sumitani m. Palliat Support Care. 2022 Apr;20(2):153-158. doi: 10.1017/S1478951521001565. Palliat Support Care. 2022. PMID: 35574912

2

Gabapentinoid Use Is Associated With Reduced Occurrence of Hyperactive Delirium in Older Cancer Patients Undergoing Chemotherapy: A Nationwide Retrospective Cohort Study in Japan.

Abe H, Sumitani M, Matsui H, Inoue R, Konishi M, Fushimi K, Uchida K, Yasunaga H. Abe H, et al. Among authors: sumitani m. Anesth Analg. 2022 Aug 1;135(2):362-369. doi: 10.1213/ANE.0000000000006093. Epub 2022 May 13. Anesth Analg. 2022. PMID: 35560025

3

Serum levels of apolipoprotein A-I and E are associated with postoperative delirium: A post hoc analysis.

Mietani K, Hasegawa-Moriyama M, Inoue R, Ogata T, Shimojo N, Kurano M, Yatomi Y, Uchida K, Sumitani M. Mietani K, et al. Among authors: sumitani m. Medicine (Baltimore). 2022 Jul 29;101(30):e29906. doi: 10.1097/MD.0000000000029906. Medicine (Baltimore). 2022. PMID: 35905282 Free PMC article.

4

Efficacy of treatments for pain and numbness in cancer survivors: a systematic review and meta-analysis.

Abe H, Inoue R, Tsuchida R, Ando M, Saita K, Konishi M, Edamura T, Ogawa A, Matsuoka Y, Sumitani M. Abe H, et al. Among authors: sumitani m. Ann Palliat Med. 2022 Dec;11(12):3674-3696. doi: 10.21037/apm-22-420. Epub 2022 Nov 18. Ann Palliat Med. 2022. PMID: 36408559 Free article.

5

Development of a Japanese Version of the Quality of Life at the End of Life-Cancer Scale.

Yamazaki T, Miyamoto S, Matsubara T, Yamagata H, Kobo H, Otani M, Abe H, Sumitani M, Shimizu K, Rodin G, Yoshiuchi K. Yamazaki T, et al. Among authors: sumitani m. J Pain Symptom Manage. 2023 Aug;66(2):e189-e195. doi: 10.1016/j.jpainsymman.2023.04.023. Epub 2023 Apr 28. J Pain Symptom Manage. 2023. PMID: 37121525

6

Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).

Kurisu K, Inada S, Maeda I, Nobata H, Ogawa A, Iwase S, Uchida M, Akechi T, Amano K, Nakajima N, Morita T, Sumitani M, Yoshiuchi K. Kurisu K, et al. Among authors: sumitani m. Support Care Cancer. 2024 Feb 8;32(3):147. doi: 10.1007/s00520-024-08352-2. Support Care Cancer. 2024. PMID: 38326487 Free PMC article.

7

Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker.

Inoue R, Sumitani M, Ogata T, Chikuda H, Matsubara T, Kato S, Shimojo N, Uchida K, Yamada Y. Inoue R, et al. Among authors: sumitani m. Neurosci Lett. 2017 Jul 13;653:39-44. doi: 10.1016/j.neulet.2017.05.023. Epub 2017 May 11. Neurosci Lett. 2017. PMID: 28504118

8

Elevated neuron-specific enolase level is associated with postoperative delirium and detection of phosphorylated neurofilament heavy subunit: A prospective observational study.

Mietani K, Hasegawa-Moriyama M, Inoue R, Ogata T, Shimojo N, Kurano M, Sumitani M, Uchida K. Mietani K, et al. Among authors: sumitani m. PLoS One. 2021 Nov 19;16(11):e0259217. doi: 10.1371/journal.pone.0259217. eCollection 2021. PLoS One. 2021. PMID: 34797829 Free PMC article.

9

Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid-induced constipation: A nationwide retrospective cohort study in Japan.

Abe H, Sumitani M, Matsui H, Inoue R, Fushimi K, Uchida K, Yasunaga H. Abe H, et al. Among authors: sumitani m. Pharmacotherapy. 2022 Mar;42(3):241-249. doi: 10.1002/phar.2658. Epub 2022 Jan 21. Pharmacotherapy. 2022. PMID: 34967450

10

Elevation of serum plasminogen activator inhibitor-1 predicts postoperative delirium independent of neural damage: a sequential analysis.

Mietani K, Hasegawa-Moriyama M, Yagi K, Inoue R, Ogata T, Shimojo N, Seto Y, Uchida K, Sumitani M. Mietani K, et al. Among authors: sumitani m. Sci Rep. 2022 Oct 12;12(1):17091. doi: 10.1038/s41598-022-21682-7. Sci Rep. 2022. PMID: 36224337 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters